Les récepteurs d’entrée du HTLV-1 : un ménage à trois

The worldwide COVID-19 pandemic has sparked intense curiosity within the speedy improvement of vaccines in addition to animal fashions to guage vaccine candidates and to outline immune correlates of safety. We lately reported a mouse-adapted SARS-CoV-2 virus pressure (MA10) with the potential to contaminate wild-type laboratory mice, driving excessive ranges of viral replication in respiratory tract tissues in addition to extreme medical and respiratory signs, points of COVID-19 illness in people which are necessary to seize in mannequin techniques.

We evaluated the immunogenicity and protecting efficacy of novel rhesus adenovirus serotype 52 (RhAd52) vaccines in opposition to MA10 problem in mice. Baseline seroprevalence is decrease for rhesus adenovirus vectors than for human or chimpanzee adenovirus vectors, making these vectors enticing candidates for vaccine improvement.

We noticed that RhAd52 vaccines elicited sturdy binding and neutralizing antibody titers, which inversely correlated with viral replication after problem. These information help the event of RhAd52 vaccines and the usage of the MA10 problem virus to display screen novel vaccine candidates and to review the immunologic mechanisms that underscore safety from SARS-CoV-2 problem in wild-type mice.

Significance We have now developed a sequence of SARS-CoV-2 vaccines utilizing rhesus adenovirus serotype 52 (RhAd52) vectors, which reveals a decrease seroprevalence than human and chimpanzee vectors, supporting their improvement as novel vaccine vectors or in its place Advert vector for enhancing.

We sought to check these vaccines utilizing a lately reported mouse-adapted SARS-CoV-2 (MA10) virus to i) consider the protecting efficacy of RhAd52 vaccines and ii) additional characterize this mouse-adapted problem mannequin and probe immune correlates of safety.

Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-1mg
QP13421-1mg	EnQuireBio	1mg	EUR 1273.2

Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-500ug
QP13421-500ug	EnQuireBio	500ug	EUR 795.6

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-100ug
QP13422-100ug	EnQuireBio	100ug	EUR 261.6

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-1mg
QP13422-1mg	EnQuireBio	1mg	EUR 1273.2

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-500ug
QP13422-500ug	EnQuireBio	500ug	EUR 795.6

SARS Associated Spike Mosaic S(M) Protein
20-abx260155	Abbexa	EUR 1062.00 EUR 410.40 EUR 1646.40	0.5 mg 100 ug 1 mg

SARS Associated Spike Mosaic S(N) Protein
20-abx260157	Abbexa	EUR 1062.00 EUR 410.40 EUR 1646.40	0.5 mg 100 ug 1 mg

(S)-Crizotinib
A8802-S	ApexBio	Evaluation Sample	EUR 97.2
Description: (S)-crizotinibthe selectively inhibited MTH1 catalytic activity with IC50 of 72 nM, while clinically used (R)-enantiomer of the drug was inactive with IC50 of 1375 nM.

Demeton S
S-1141	Scientific Laboratory Supplies	1ML	EUR 131.1

SARS-CoV-2 S Recombinant Antibody, HRP Conjugated
A73673	EpiGentek	EUR 377.30 EUR 518.10	50 ul 100 ul

SARS-CoV-2 S Recombinant Antibody, FITC Conjugated
A73674	EpiGentek	EUR 377.30 EUR 518.10	50 ul 100 ul

SARS-CoV-2 S Recombinant Antibody, Biotin Conjugated
A73675	EpiGentek	EUR 377.30 EUR 518.10	50 ul 100 ul

SARS-CoV-2 S Recombinant Antibody, HRP Conjugated
A73673-050	EpiGentek	50 ul	EUR 377.3

SARS-CoV-2 S Recombinant Antibody, HRP Conjugated
A73673-100	EpiGentek	100 ul	EUR 518.1

SARS-CoV-2 S Recombinant Antibody, FITC Conjugated
A73674-050	EpiGentek	50 ul	EUR 377.3

SARS-CoV-2 S Recombinant Antibody, FITC Conjugated
A73674-100	EpiGentek	100 ul	EUR 518.1

SARS-CoV-2 S Recombinant Antibody, Biotin Conjugated
A73675-050	EpiGentek	50 ul	EUR 377.3

SARS-CoV-2 S Recombinant Antibody, Biotin Conjugated
A73675-100	EpiGentek	100 ul	EUR 518.1

SARS-CoV S Recombinant Protein (R667A, K968P, V969P)
11-115	ProSci	0.1 mg	EUR 884.4
Description: It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant SARS Spike Mosaic Protein S (N-Terminal)
VAng-Lsx0073-inquire	Creative Biolabs	inquire	Ask for price
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli.

Recombinant SARS S Protein (aa 1-1190) [His]
VAng-Lsx0060-inquire	Creative Biolabs	inquire	Ask for price
Description: SARS Surface Antigen (aa 1-1190) [His], recombinant protein from HEK 293 cells.

Recombinant SARS Associated Spike Mosaic S(N)
7-07093	CHI Scientific	100µg	Ask for price

Recombinant SARS Associated Spike Mosaic S(N)
7-07094	CHI Scientific	500µg	Ask for price

Recombinant SARS Associated Spike Mosaic S(N)
7-07095	CHI Scientific	1000µg	Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07096	CHI Scientific	100µg	Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07097	CHI Scientific	500µg	Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07098	CHI Scientific	1000µg	Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07099	CHI Scientific	100µg	Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07100	CHI Scientific	500µg	Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07101	CHI Scientific	1000µg	Ask for price

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1422	Alpha Diagnostics	100 ug	EUR 343.2

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1423	Alpha Diagnostics	100 ug	EUR 343.2

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1424	Alpha Diagnostics	100 ug	EUR 343.2

SARS-CoV-2 (COVID-19) S RBD Recombinant Protein
10-413	ProSci	0.1 mg	EUR 714.3
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S RBD Recombinant Protein
10-431	ProSci	0.1 mg	EUR 714.3
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Recombinant Protein RBD
11-215	ProSci	0.2 mg	EUR 1086
Description: It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S-trimer Recombinant Protein
11-070	ProSci	0.1 mg	EUR 695.4
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S RBD Recombinant Protein
97-093	ProSci	0.1 mg	EUR 714.3
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, DPP4, CEACAM etc.. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant Coronavirus Spike Protein (SARS-CoV S, His tag)
P1520-10	Biovision	10µg	EUR 308.4

SARS antibody
70R-20086	Fitzgerald	50 ul	EUR 522
Description: Rabbit polyclonal SARS antibody

SARS antibody
70R-1444	Fitzgerald	100 ug	EUR 452.4
Description: Rabbit polyclonal SARS antibody raised against the C terminal of SARS

SARS antibody
70R-1445	Fitzgerald	100 ug	EUR 452.4
Description: Rabbit polyclonal SARS antibody raised against the middle region of SARS

SARS antibody
39139-100ul	SAB	100ul	EUR 302.4

SARS Antibody
DF15539	Affbiotech	100ul	EUR 420

SARS Antibody
1-CSB-PA04145A0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

SARS Antibody
1-CSB-PA020709GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against SARS. Recognizes SARS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

SARS-CoV-2 (COVID-19) S Protein RBD Recombinant Protein
10-433	ProSci	0.1 mg	EUR 714.3
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Protein NTD Recombinant Protein
92-738	ProSci	0.05 mg	EUR 468.6
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Protein HR1 Recombinant Protein
92-760	ProSci	0.05 mg	EUR 468.6
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. After binding of RBD in S1 subunit of S protein on the virion to the ACE2 receptor on the target cell, the heptad repeat 1 (HR1) and 2 (HR2) domains in its S2 subunit of S protein interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Protein HR1 Recombinant Protein
92-761	ProSci	0.05 mg	EUR 468.6
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. After binding of RBD in S1 subunit of S protein on the virion to the ACE2 receptor on the target cell, the heptad repeat 1 (HR1) and 2 (HR2) domains in its S2 subunit of S protein interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Demeton (O and S)
S-1140	Scientific Laboratory Supplies	1ML	EUR 71.82

SARS N Protein Antibody
abx018255-100ug	Abbexa	100 ug	EUR 460.8

SARS N Protein Antibody
abx018256-100ug	Abbexa	100 ug	EUR 460.8

SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein
10-075	ProSci	0.1 mg	EUR 991.5
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). The CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. Although both SARS-CoV and SARS-CoV-2 bind the ACE2 receptor, the RBDs only share ~73% amino acid identity, and the SARS-CoV-2 RBD binds with a higher affinity compared to SARS-CoV 3, 6. The RBD is dynamic and undergoes hinge-like conformational changes, referred to as the “down” or “up” conformations, which hide or expose the receptor-binding motifs, respectively 7. Following receptor binding, S1 destabilizes, and TMPRSS2 cleaves S2, which undergoes a pre- to post-fusion conformation transition, allowing for membrane fusion 8, 9. The S protein has been the main focus of therapeutic and vaccine design as it is highly immunogenic. Both neutralizing antibodies 10,11 and memory T cells 12,13 targeting the S protein are present in the sera of convalescent COVID-19 patients.

SARS-CoV-2 (COVID-19) Spike S Trimer Recombinant Protein
20-182	ProSci	0.1 mg	EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S-trimer 6P Recombinant Protein
11-068	ProSci	0.1 mg	EUR 714.3
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S + M + E Recombinant Protein
11-071	ProSci	0.1 mg	EUR 695.4
Description: Coronavirus envelope (E) proteins are short (100 residues) polypeptides that contain at least one transmembrane (TM) domain and a cluster of 2-3 juxtamembrane cysteines. These proteins are involved in viral morphogenesis and tropism, and their absence leads in some cases to aberrant virions, or to viral attenuation. In common to other viroporins, coronavirus envelope proteins increase membrane permeability to ions, plays a central role in virus morphogenesis and assembly. Acts as a viroporin and self-assembles in host membranes forming pentameric protein-lipid pores that allow ion transport. Also plays a role in the induction of apoptosis. Activates the host NLRP3 inflammasome, leading to IL-1beta overproduction.

SARS-CoV-2 (COVID-19) S-trimer (D614G) Recombinant Protein
92-748	ProSci	0.05 mg	EUR 619.8
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell atthe advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acuterespiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusionrequired for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's beenreported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the humanACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor.S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction ofneutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Protein RBD-SD1 Recombinant Protein
92-736	ProSci	0.05 mg	EUR 468.6
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Protein RBD-SD1 Recombinant Protein
92-737	ProSci	0.02 mg	EUR 556.8
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Protein RBD (N501Y) Recombinant Protein
92-762	ProSci	0.05 mg	EUR 569.4
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) S Protein RBD (N501Y) Recombinant Protein
92-763	ProSci	0.05 mg	EUR 569.4
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Rabbit Anti-flagellin protein (Fla/FLGN, S. typhimurium) antiserum
FLGN12-S	Alpha Diagnostics	100 ul	EUR 562.8

SARS Coronavirus antibody
10C-CR9003M1	Fitzgerald	100 ug	EUR 598.8
Description: Mouse monoclonal SARS Coronavirus antibody

SARS Nucleocapsid antibody
10R-10470	Fitzgerald	100 ug	EUR 522
Description: Mouse monoclonal SARS Nucleocapsid antibody

SARS Nucleocapsid antibody
10R-10471	Fitzgerald	100 ug	EUR 522
Description: Mouse monoclonal SARS Nucleocapsid antibody

SARS E2 antibody
10R-1976	Fitzgerald	100 ul	EUR 289.2
Description: Mouse monoclonal SARS E2 antibody

SARS M antibody
10R-1977	Fitzgerald	100 ul	EUR 289.2
Description: Mouse monoclonal SARS M antibody

SARS Spike Antibody
24216-100ul	SAB	100ul	EUR 468

SARS Spike Antibody
24217-100ul	SAB	100ul	EUR 468

SARS Spike Antibody
24218-100ul	SAB	100ul	EUR 468

SARS Spike Antibody
24219-100ul	SAB	100ul	EUR 468

SARS Spike Antibody
24318-100ul	SAB	100ul	EUR 468

SARS Matrix Antibody
24319-100ul	SAB	100ul	EUR 468

SARS Matrix Antibody
24320-100ul	SAB	100ul	EUR 468

SARS Envelope Antibody
24321-100ul	SAB	100ul	EUR 468

SARS Envelope Antibody
24322-100ul	SAB	100ul	EUR 468

SARS Spike Antibody
20-abx137184	Abbexa	EUR 1262.40 EUR 1846.80 EUR 2064.00	100 ug 200 ug 300 µg

SARS Nucleocapsid Antibody
20-abx137185	Abbexa	EUR 1262.40 EUR 1846.80 EUR 2364.00	100 ug 200 ug 300 µg

SARS Spike Antibody
20-abx137200	Abbexa	EUR 1412.40 EUR 2264.40 EUR 2665.20	100 ug 200 ug 300 µg

SARS Nucleocapsid Antibody
20-abx137201	Abbexa	EUR 1412.40 EUR 2264.40 EUR 2665.20	100 ug 200 ug 300 µg

SARS-E2 Antibody
abx016055-100ul	Abbexa	100 ul	EUR 493.2

SARS-M Antibody
abx016056-100ul	Abbexa	100 ul	EUR 493.2

SARS Conjugated Antibody
C39139	SAB	100ul	EUR 476.4

Anti-SARS antibody
PAab07609	Lifescience Market	100 ug	EUR 463.2

anti- SARS antibody
FNab07609	FN Test	100µg	EUR 658.5
Description: Antibody raised against SARS

Anti-SARS antibody
STJ115313	St John's Laboratory	100 µl	EUR 332.4
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

Anti-SARS antibody
STJ28816	St John's Laboratory	100 µl	EUR 332.4
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

SARS Polyclonal Antibody
A53977-020	EpiGentek	20 ul	EUR 117.7

SARS Polyclonal Antibody
A53977-050	EpiGentek	50 ul	EUR 302.5

SARS Polyclonal Antibody
A53977-100	EpiGentek	100 ul	EUR 423.5

SARS Polyclonal Antibody
A53977	EpiGentek	EUR 684.66 EUR 117.70 EUR 302.50 EUR 423.50	100 µg 20 ul 50 ul 100 ul

SARS Polyclonal Antibody
A71293	EpiGentek	EUR 302.50 EUR 423.50	50 ul 100 ul

SARS Polyclonal Antibody
A71293-050	EpiGentek	50 ul	EUR 302.5

SARS Polyclonal Antibody
A71293-100	EpiGentek	100 ul	EUR 423.5

Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial
E80028	EpiGentek	EUR 388.30 EUR 860.20	20 ul 100 ul

Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial
E80028-1	EpiGentek	20 ul	EUR 388.3

Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial
E80028-2	EpiGentek	100 ul	EUR 860.2

Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573)
VAng-Lsx0056-inquire	Creative Biolabs	inquire	Ask for price
Description: Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

SARS-CoV spike protein Antibody
abx023139-100ug	Abbexa	100 ug	EUR 1028.4

SARS-CoV spike protein Antibody
abx023143-100ug	Abbexa	100 ug	EUR 1028.4

Bisphenol S 1000 ug/mL in Methanol
S-5871	Scientific Laboratory Supplies	1ML	EUR 109.44

1000 ug/mL (S)-(-)-Limonene in Ethanol
S-6409	Scientific Laboratory Supplies	1ML	EUR 88.92

Sars/ Rat Sars ELISA Kit
ELI-41050r	Lifescience Market	96 Tests	EUR 1063.2

Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug
QP10499-100ug	EnQuireBio	100ug	EUR 261.6

Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg
QP10499-1mg	EnQuireBio	1mg	EUR 1273.2

Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug
QP10499-500ug	EnQuireBio	500ug	EUR 795.6

Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug
QP13416-100ug	EnQuireBio	100ug	EUR 261.6

Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg
QP13416-1mg	EnQuireBio	1mg	EUR 1273.2

Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug
QP13416-500ug	EnQuireBio	500ug	EUR 795.6

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-100ug
QP13417-100ug	EnQuireBio	100ug	EUR 261.6

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-1mg
QP13417-1mg	EnQuireBio	1mg	EUR 1273.2

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-500ug
QP13417-500ug	EnQuireBio	500ug	EUR 795.6

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-100ug
QP13418-100ug	EnQuireBio	100ug	EUR 261.6

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-1mg
QP13418-1mg	EnQuireBio	1mg	EUR 1273.2

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-500ug
QP13418-500ug	EnQuireBio	500ug	EUR 795.6

Recombinant SARS SARS MERS Protein, His, E.coli-100ug
QP13419-100ug	EnQuireBio	100ug	EUR 261.6

Recombinant SARS SARS MERS Protein, His, E.coli-1mg
QP13419-1mg	EnQuireBio	1mg	EUR 1513.2

Recombinant SARS SARS MERS Protein, His, E.coli-500ug
QP13419-500ug	EnQuireBio	500ug	EUR 795.6

Recombinant SARS SARS-CoV Protein, His, E.coli-1mg
QP13423-1mg	EnQuireBio	1mg	EUR 4744.8

Recombinant SARS SARS-CoV Protein, His, E.coli-20ug
QP13423-20ug	EnQuireBio	20ug	EUR 241.2

Recombinant SARS SARS-CoV Protein, His, E.coli-5ug
QP13423-5ug	EnQuireBio	5ug	EUR 186

SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD) Recombinant Protein
10-108	ProSci	0.1 mg	EUR 1186.8
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity.

SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD) Recombinant Protein
10-121	ProSci	0.1 mg	EUR 1186.8
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity.

SARS-CoV Spike Antibody
3219-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3225-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3225-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Matrix Antibody
3527-002mg	ProSci	0.02 mg	EUR 206.18
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody
3527-01mg	ProSci	0.1 mg	EUR 523.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody
3529-002mg	ProSci	0.02 mg	EUR 206.18
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody
3529-01mg	ProSci	0.1 mg	EUR 523.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Envelope Antibody
3533-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.

SARS-CoV Envelope Antibody
3533-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.

SARS virus Sn Antibody
abx032683-400ul	Abbexa	400 ul	EUR 627.6

SARS virus Sn Antibody
abx032683-80l	Abbexa	80 µl	EUR 343.2

SARS virus Sm Antibody
abx032684-400ul	Abbexa	400 ul	EUR 627.6

SARS virus Sm Antibody
abx032684-80l	Abbexa	80 µl	EUR 343.2

ACE2 (SARS Receptor) Antibody
abx032686-400ul	Abbexa	400 ul	EUR 627.6

ACE2 (SARS Receptor) Antibody
abx032686-80l	Abbexa	80 µl	EUR 343.2

Polyclonal SARS Matrix Antibody
APR11178G	Leading Biology	0.1 mg	EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SARS Matrix . This antibody is tested and proven to work in the following applications:

Polyclonal SARS Matrix Antibody
APG02976G	Leading Biology	0.1 mg	EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SARS Matrix . This antibody is tested and proven to work in the following applications:

SARS Antibody, HRP conjugated
1-CSB-PA04145B0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

SARS Antibody, FITC conjugated
1-CSB-PA04145C0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

SARS Antibody, Biotin conjugated
1-CSB-PA04145D0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Anti-SARS-E2 antibody
STJ98377	St John's Laboratory	100 µl	EUR 280.8
Description: Mouse monoclonal to SARS-E2.

Anti-SARS-M antibody
STJ98378	St John's Laboratory	100 µl	EUR 280.8
Description: Mouse monoclonal to SARS-M.

Rabbit Anti-Sm28/Smp28/GST28/GST-mu protein (S. Japonicum, 1-211aa) antiserum
SM282-S	Alpha Diagnostics	100 ul	EUR 548.4

Protein S antibody
70R-10600	Fitzgerald	500 ug	EUR 584.4
Description: Affinity purified sheep polyclonal Protein S antibody

Protein S antibody
70R-13274	Fitzgerald	100 ul	EUR 548.4
Description: Affinity purified Rabbit polyclonal Protein S antibody

Protein S antibody
20R-1388	Fitzgerald	5 mg	EUR 330
Description: Goat polyclonal Protein S antibody

Protein S antibody
20R-1389	Fitzgerald	10 mg	EUR 330
Description: Sheep polyclonal Protein S antibody

Protein S antibody
22939-100ul	SAB	100ul	EUR 468

Protein S antibody
70R-6073	Fitzgerald	50 ug	EUR 560.4
Description: Rabbit polyclonal Protein S antibody

Rabbit Anti-S. Pneumococcal Serotype 23F Carbohydrate (Spn23F) Antiserum
SPN231-S	Alpha Diagnostics	100 ul	EUR 534

1000ug/mL of S-Metolachlor in Acetonitrile 1mL ampule
S-5203	Scientific Laboratory Supplies	1ML	EUR 328.32

SARS siRNA
20-abx904776	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

SARS siRNA
20-abx932473	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

SARS siRNA
20-abx932474	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

pENTR223-SARS
PVT12269	Lifescience Market	2 ug	EUR 469.2

SARS Nucleocapsid Recombinant Protein
10-213	ProSci	0.1 mL	EUR 752.1
Description: The nucleocapsid (N) protein of SARS-coronavirus (SARS-CoV) is the key protein for the formation of the helical nucleocapsid during virion assembly. The nucleocapsid (N) protein of SARS-CoV enters the host cell together with the viral RNA and interferes with several cellular processes. Some of these processes involve interactions between SARS-CoV N protein and host- cell proteins. It has also been demonstrated that the SARS-CoV N protein can bind to DNA in vitro. These interactions might have a role in the pathology of SARS. The N protein may be of potential value in vaccine development for specific prophylaxis and treatment against SARS.

SARS CoV E Protein
abx060650-1mg	Abbexa	1 mg	EUR 2030.4

SARS CoV Nucleocapsid Protein
abx060652-1mg	Abbexa	1 mg	EUR 2247.6

SARS-CoV Nucleocapsid Protein
abx060653-1mg	Abbexa	1 mg	EUR 2030.4

SARS-CoV Nucleocapsid Protein
abx060654-1mg	Abbexa	1 mg	EUR 2030.4

SARS-CoV Spike Protein
abx060655-1mg	Abbexa	1 mg	EUR 2030.4

SARS protein (His tag)
80R-2099	Fitzgerald	50 ug	EUR 386.4
Description: Recombinant human SARS protein (His tag)

SARS Protein Detection Set
PSI-1810	ProSci	1 Set	EUR 884.4
Description: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral S (Spike) protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. The M protein (Membrane protein, Matrix protein) is another major structural viral protein. It is an integral membrane protein involved in the budding of the viral particles and interacts with S protein and the nucleocapsid protein. The SARS E protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. ACE2, the SARS receptor, normally plays a central role in vascular, renal, and myocardial physiology. In contrast to its homolog ACE, ACE2 expression is restricted to heart, kidney, and testis.;;For images please see PDF data sheet

SARS Recombinant Protein (Human)
RP027604	ABM	100 ug	Ask for price

SARS Recombinant Protein (Human)
RP027607	ABM	100 ug	Ask for price

SARS Recombinant Protein (Rat)
RP227480	ABM	100 ug	Ask for price

SARS Recombinant Protein (Mouse)
RP170009	ABM	100 ug	Ask for price

SARS Recombinant Protein (Mouse)
RP170012	ABM	100 ug	Ask for price

Recombinant SARS Matrix Protein
VAng-Lsx0059-inquire	Creative Biolabs	inquire	Ask for price
Description: SARS Matrix, recombinant protein from E. coli.

Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203)
VAng-Lsx0055-inquire	Creative Biolabs	inquire	Ask for price
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190)
VAng-Lsx0057-inquire	Creative Biolabs	inquire	Ask for price
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS-CoV-2 S1+S2 ECD (S-ECD) Protein with His-Tag
E80002-1	EpiGentek	100 ul	EUR 848.1

Peptidoglycan Recognition Protein-S (PGRP-S) Antibody
abx433127-200ul	Abbexa	200 ul	EUR 460.8

Rabbit Anti-Rat Dopamine Receptor 2 (D2R) (L/S) Antiserum # 1
D2R11-S	Alpha Diagnostics	100 ul	EUR 548.4

Rabbit Anti-Human Dopamine Receptor 2 (D2R) (L/S) Ab # 3
D2R13-S	Alpha Diagnostics	100 ul	EUR 548.4

Rabbit Anti-Glutathione Transferase, GST (S. japonicum, E. coli) antiserum # 1
GST11-S	Alpha Diagnostics	100 ul	EUR 548.4

SARS-CoV-2 N Protein Monoclonal Antibody
A73663	EpiGentek	EUR 341.00 EUR 518.10	50 ul 100 ul

SARS-CoV-2 N Protein Monoclonal Antibody
A73663-050	EpiGentek	50 ul	EUR 341

SARS-CoV-2 N Protein Monoclonal Antibody
A73663-100	EpiGentek	100 ul	EUR 518.1

We show RhAd52 vaccines elicit sturdy SARS-CoV-2-specific antibody responses and defend in opposition to medical illness and viral replication within the lungs. Additional, binding and neutralizing antibody titers correlated with protecting efficacy. These information validate the MA10 mouse mannequin as a useful gizmo to display screen and research novel vaccine candidates, in addition to the event of RhAd52 vaccines for COVID-19.